VirTrial has announced its international expansion with a newly appointed International Director of Business Development, a network of virtual trial capable research sites across 31 countries, policies supporting GDPR compliance, and product enhancements that support language translation into any left to right reading language, the company said.
Recognizing the need to support VirTrial´s customers around the globe, Emil Hoeck has been named International Director of Business Development and will be based in Denmark. Hoeck´s CRO and site background makes him an ideal candidate to manage company interests abroad including strategic customer and site relationships across Europe and new international partnerships.
VirTrial´s Virtual Care Management (VCM) platform is HIPAA, HITECH and Privacy Shield Compliant and VirTrial has implemented policies to support GDPR compliance. The mobile app and web interface can be translated and displayed into any left to right reading language worldwide.
VirTrial is a telemedicine company providing a stable, long-standing virtual care management (VCM) platform to transform the clinical trial industry. The platform combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric Decentralized Clinical Trials (DCTs) by replacing some study visits with virtual visits.